Posted on by

FDA approves Biogen’s Alzheimer’s drug, the first new therapy for the disease in nearly two decades



Share

The drug, which is marketed under the name Aduhelm, is expected to generate billions of dollars in revenue for the company.

Read More

Related posts:

"The Power of AI in Business and Entrepreneurship: Unlocking Opportunities and Driving Success"
"The Power of AI: Revolutionizing Business and Empowering Entrepreneurs"
Margaritaville Aims to Hang On After Jimmy Buffett’s Death
Pork Industry Grapples With Whiplash of Shifting Regulations


Amplifying Patient Voices: White Swan’s AI-Driven Approach to Transforming Healthcare

April 28, 2024
Read More...

Revolutionizing Chemotherapy: Carole Spangler Vaughn’s Breakthrough in Combatting Peripheral Neuropathy

April 28, 2024
Read More...

The Future of AI in Marketing: Insights from Erik Huberman at the 2024 Global AI Conference

April 16, 2024
Read More...

Revolutionizing Hospitality: How Predictive Personalization Boosts Revenue

April 16, 2024
Read More...

Integrating AI in Humanoids and Deep Tech: A Strategic Insight with Shaloo Garg at the 2024 Global AI Conference

April 16, 2024
Read More...

How Generative AI is Revolutionizing the Retail Industry: Insights from Microsoft’s ShiSh Shridhar

April 14, 2024
Read More...

From Inspiration to Impact: Julie Davitz’s Vision for Transformative Media Engagement

March 31, 2024
Read More...

Empowering Small Businesses: Jeffery Boyle’s Vision of Accessible AI with Bemodo

March 31, 2024
Read More...

Josh Mangum at 1MediaWorld: Mastering the Human-AI Nexus for Business Success

March 31, 2024
Read More...

Navigating the Nexus of Filmmaking and Financial Reform: The Tobias Deml Blueprint

March 28, 2024
Read More...